Sign In
Buy ARVN
$7.70
-0.300 (-3.75%)
At Close: Jun 03, 2026
Arvinas Inc (NASDAQ:ARVN) Shares Purchased by Bank of America Corp DE
08:36am, Thursday, 09'th Apr 2020
Bank of America Corp DE boosted its holdings in shares of Arvinas Inc (NASDAQ:ARVN) by 1,408.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exch
Arvinas Inc (NASDAQ:ARVN) Expected to Post Quarterly Sales of $5.18 Million
06:32am, Thursday, 09'th Apr 2020
Brokerages predict that Arvinas Inc (NASDAQ:ARVN) will post sales of $5.18 million for the current quarter, according to Zacks. Three analysts have made estimates for Arvinas’ earnings, with estimat
Arvinas Inc (NASDAQ:ARVN) Given Consensus Rating of "Buy" by Analysts
07:28am, Tuesday, 07'th Apr 2020
Shares of Arvinas Inc (NASDAQ:ARVN) have earned a consensus rating of “Buy” from the fourteen brokerages that are presently covering the firm, Marketbeat.com reports. Two equities research analyst
'There is no magic bullet': the town that turned the tide against HIV
04:00am, Tuesday, 07'th Apr 2020
Lessons learned in Eshowe, South Africa, one of the areas worst hit by the HIV pandemic, are being used in the fight against coronavirus
Cubist Systematic Strategies LLC Purchases 28,348 Shares of Arvinas Inc (NASDAQ:ARVN)
10:08am, Saturday, 04'th Apr 2020
Cubist Systematic Strategies LLC increased its stake in Arvinas Inc (NASDAQ:ARVN) by 1,375.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm o
Credit Suisse AG Has $1.09 Million Stake in Arvinas Inc (NASDAQ:ARVN)
10:20am, Wednesday, 01'st Apr 2020
Credit Suisse AG boosted its stake in Arvinas Inc (NASDAQ:ARVN) by 105.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The insti
Arvinas to Present at the American Society of Clinical Oncology Annual Meeting
11:00am, Tuesday, 31'st Mar 2020
Arvinas, Inc. (ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced the acceptance of an abstract for presentation at the
The Arvinas, Inc. (NASDAQ:ARVN) Analysts Have Been Trimming Their Sales Forecasts
10:27am, Tuesday, 31'st Mar 2020
The analysts covering Arvinas, Inc. (NASDAQ:ARVN) delivered a dose of negativity to shareholders today, by making a...
FY2020 Earnings Forecast for Arvinas Inc Issued By Cantor Fitzgerald (NASDAQ:ARVN)
06:52am, Monday, 30'th Mar 2020
Arvinas Inc (NASDAQ:ARVN) – Stock analysts at Cantor Fitzgerald cut their FY2020 earnings per share (EPS) estimates for shares of Arvinas in a report released on Wednesday, March 25th. Cantor Fitzge
Briggs Morrison Acquires 2,500 Shares of Arvinas Inc (NASDAQ:ARVN) Stock
10:22am, Friday, 27'th Mar 2020
Arvinas Inc (NASDAQ:ARVN) Director Briggs Morrison acquired 2,500 shares of Arvinas stock in a transaction dated Tuesday, March 24th. The shares were bought at an average cost of $40.82 per share, wit
Algert Global LLC Takes $440,000 Position in Arvinas Inc (NASDAQ:ARVN)
08:28am, Friday, 27'th Mar 2020
Algert Global LLC purchased a new stake in Arvinas Inc (NASDAQ:ARVN) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The inst
Some Analysts Just Cut Their Arvinas, Inc. (NASDAQ:ARVN) Estimates
10:06am, Thursday, 26'th Mar 2020
The latest analyst coverage could presage a bad day for Arvinas, Inc. (NASDAQ:ARVN), with the analysts making...
DZ Bank likes Medtronic in premarket analyst action
11:14am, Wednesday, 25'th Mar 2020
Menlo Therapeutics (NASDAQ:MNLO) initiated with Overweight rating and $8 (161% upside) price target at Barclays.Molecular Templates (NASDAQ:MTEM) initiated with Buy rating and $19 (43% upside) price t
Ian Taylor Sells 826 Shares of Arvinas Inc (NASDAQ:ARVN) Stock
10:38am, Wednesday, 25'th Mar 2020
Arvinas Inc (NASDAQ:ARVN) insider Ian Taylor sold 826 shares of the company’s stock in a transaction on Thursday, March 19th. The shares were sold at an average price of $37.61, for a total transact
Arvinas (NASDAQ:ARVN) Shares Up 8.2% Following Insider Buying Activity
06:44am, Wednesday, 25'th Mar 2020
Arvinas Inc (NASDAQ:ARVN) shot up 8.2% during trading on Tuesday after an insider bought additional shares in the company. The stock traded as high as $39.82 and last traded at $38.00, 365,640 shares
